IMARC Group, a leading market research company, has recently releases report titled “Women's Health Diagnostics Market Report by Type (Diagnostic Devices, Diagnostic Tests), Application (Breast Cancer, Infectious Disease Testing, Osteoporosis Testing, Pregnancy and Fertility Testing, Sexually Transmitted Disease Testing, and Others), End User (Hospital and Diagnostics Centers, Home Care), and Region 2024-2032",Offers a comprehensive analysis of the industry, which comprises insights on the women's health diagnostics market share.
How Big is the Women's Health Diagnostics Market?
The global women's health diagnostics market size reached US$ 29.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 52.6 Billion by 2032, exhibiting a growth rate (CAGR) of 6.6% during 2024-2032.
Industry Overview of Women's Health Diagnostics
Women's health diagnostics refer to a set of medical evaluations and tests designed to assess and monitor various aspects of the health of a woman. They rely on liquid profiles, blood pressure monitoring, and electrocardiograms to help evaluate health complications. They also encompass the conduction of regular screenings, such as mammograms, pap smears, and bone density tests, for the early detection of conditions like breast cancer, cervical cancer, and osteoporosis. They cover a wide array of areas, including reproductive health, hormonal balance, bone density, cardiovascular health, and more. They also provide early interventions and targeted treatments, which contribute to lower mortality rates.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/womens-health-diagnostics-market/requestsample
What are the growth prospects and trends in the women's health diagnostics industry?
At present, the increasing demand for women’s health diagnostic services as early disease detection and prevention reduces the financial burden on healthcare systems, represents one of the vital factors impelling the growth of the market.
Besides this, the rising implementation of women’s health diagnostics to decrease the need for extensive treatments and hospitalizations is propelling the growth of the market. In addition, the growing demand for innovative and accurate diagnostic tools tailored to women's specific health needs, including breast and cervical cancer screening, prenatal testing, and hormonal health assessments, is offering a favorable market outlook.
Apart from this, the increasing technological advancements in diagnostic methodologies, including the integration of artificial intelligence (AI) and machine learning (ML) algorithms, are supporting the growth of the market.
Leading Companies Operating in the Global Women's Health Diagnostics Industry:
- Abbott Laboratories
- Becton Dickinson and Company
- bioMérieux SA
- Cardinal Health Inc.
- Cook Group Incorporated
- F. Hoffmann-La Roche AG
- General Electric Company
- Hologic Inc.
- Koninklijke Philips N.V.
- Perkinelmer Inc.
- Quest Diagnostics Inc.
- Siemens AG
- Thermo Fisher Scientific Inc.
Women's Health Diagnostics Market Segmentation:
The report has segmented the market into the following categories:
Breakup by Type:
- Diagnostic Devices
o Biopsy Device
o Imaging and Monitoring Devices
o Accessories and Consumables
- Diagnostic Tests
o Breast Cancer Testing
o PAP Smear and HPV Test
o Pregnancy Testing and Ovulation Testing
o Others
Breakup by Application:
- Breast Cancer
- Infectious Disease Testing
- Osteoporosis Testing
- Pregnancy and Fertility Testing
- Sexually Transmitted Disease Testing
- Others
Breakup by End User:
- Hospital and Diagnostics Centers
- Home Care
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
